Indian Giants Turn to Global Markets Amid Domestic Slowdown
In a significant move, Indian conglomerates like Sun Pharmaceuticals and Coforge are acquiring foreign companies to counteract the slowing growth at home. Sun Pharma's $11.75 billion acquisition of Organon & Co. highlights the trend. This strategic pivot allows Indian firms …
Read more →
